Patents

• Page 4 of 4 (35 items) First 1 2 3 4 

• IP Rules for Synthetic Bio Generate More Questions Than Answers
  Among unresolved issues are gene patentability, patent protection vs. open access, and the effect of patent reform.
• House Takes Different Stance from Senate on Two Key Factors in Patent Reform
  While in number the amendments are small, their influence could be significant.
• Stanford v. Roche Could Place Tech Transfer on Shaky Ground
  If Supreme Court doesn’t overturn previous decision, patent ownership may become tough to verify and impede licensing.
• 2010 in Review: Biotechnology Highlights
  Gene patenting and ESCs were back in the headlines along with breakthroughs in sequencing, syn bio, and other fields.
• FTC Challenges to Patent Settlements Entering a New Stage
  Recent rulings suggest that the FTC will need to act against these settlements within the framework of existing case law.

• Page 4 of 4 (35 items) First 1 2 3 4